Weight-Chronic Kidney Disease (CKD) is a long-term condition that affects millions of people worldwide. Patients with CKD experience a wide range of symptoms such as fatigue, itching, sleep problems, pain, nausea, and difficulty concentrating….
Drugs – In recent years, medications known as GLP-1 receptor agonists have transformed the landscape of obesity management. Drugs like Ozempic, Wegovy, and Mounjaro, originally developed for diabetes, are now being widely used for weight loss. As their popularity grows, doctors are seeing more patients using these medications before considering weight-loss surgery (bariatric surgery).
From Diabetes Treatment to Weight Loss Trend Over the past few years, Ozempic has transformed from a niche prescription drug for type 2 diabetes into a household name synonymous with weight loss. The medication, whose active ingredient is semaglutide, was originally developed to help regulate blood sugar levels. But as more people began using it, an unintended side effect—significant weight loss—pushed Ozempic into the spotlight and fueled a cultural phenomenon.
Weight Loss Risk – In a significant move aimed at enhancing drug safety, the U.S. Food and Drug Administration (FDA) has mandated expanded labeling for certain weight loss medications, particularly those prescribed to younger populations.
In a significant move affecting the weight-loss and diabetes treatment landscape, the U.S. Food and Drug Administration (FDA) has..
